Could the authors elaborate on how the model’s robustness was evaluated across different seizure types? Given that epileptic seizures vary in duration and intensity, were any additional validation steps taken to ensure the model’s performance across diverse patient conditions?
Additionally, while the leave-one-patient-out cross-validation is a strong approach, were any statistical significance tests performed to compare the model’s performance against other state-of-the-art methods?